Le Lézard
Classified in: Health
Subjects: LEG, WOM, AVO

The National Women's Law Center Launches Initiative to Protect Abortion Rights


WASHINGTON, July 16, 2019 /PRNewswire/ -- Today, the National Women's Law Center (NWLC) launched the Abortion Rights Project to respond to the unprecedented assault on abortion rights in this country. A major focus of the initiative will be supporting state and local groups working on the frontlines of the fight to protect the right to abortion and expand abortion access. The Abortion Rights Project is providing an initial investment of $350,000 to 11 groups across the country doing critical work to keep clinics open, help people access abortion care, drive public education and narrative change on abortion, engage in grassroots organizing especially among communities of color, challenge abortion restrictions, and strengthen abortion rights. It will also provide these organizations delivering vital services with legal and technical assistance, as well as research, analysis, and grassroots media and visibility efforts.

National Women's Law Center

"Our country is engaged in one of the greatest gender justice fights of our time," said Fatima Goss Graves, President & CEO of NWLC. "Anti-abortion politicians are banning abortion, shutting down clinics, criminalizing providers, and shaming women who seek an abortion. Make no mistake: an abortion ban in Georgia is the same as the attempt to shut down an abortion clinic in Arkansas, and these are the same as the next attack in the next state. This is a coordinated effort to end abortion at any cost, and to strip away our rights to safety, dignity, and equality."

As part of the Abortion Rights Project, a national public education campaign will engage and mobilize the public, strengthened by local and state efforts led by our partner groups. The campaign will work to achieve a national landscape where all of us, no matter our race, income, zip code, immigration status, or gender, can safely access abortion with dignity.

The Abortion Rights Project's inaugural launch partners include:

For more information on NWLC's Abortion Rights Project, including donation information, please visit: www.nwlc.org/abortionrightsproject.

The National Women's Law Center fights for gender justice ? in the courts, in public policy, and in our society ? working across the issues that are central to the lives of women and girls. We use the law in all its forms to change culture and drive solutions to the gender inequity that shapes our society and to break down the barriers that harm all of us ? especially those who face multiple forms of discrimination, including women of color, LGBTQ people, and low-income women and families. For more than 45 years, we have been on the leading edge of every major legal and policy victory for women. Find out more at NWLC.org.

Contact: LySaundra Campbell, [email protected]

 

SOURCE National Women's Law Center


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: